Annual ROA
-358.75%
-127.27%-54.98%
December 1, 2023
Summary
- As of February 7, 2025, RNAZ annual return on assets is -358.75%, with the most recent change of -127.27% (-54.98%) on December 1, 2023.
- During the last 3 years, RNAZ annual ROA has fallen by -136.66% (-61.53%).
- RNAZ annual ROA is now -1102.65% below its all-time high of -29.83%, reached on December 31, 2021.
Performance
RNAZ ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROA
-281.35%
-21.03%-8.08%
September 1, 2024
Summary
- As of February 7, 2025, RNAZ quarterly return on assets is -281.35%, with the most recent change of -21.03% (-8.08%) on September 1, 2024.
- Over the past year, RNAZ quarterly ROA has dropped by -13.76% (-5.14%).
- RNAZ quarterly ROA is now -728.72% below its all-time high of -33.95%, reached on March 31, 2022.
Performance
RNAZ Quarterly ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROA Formula
ROA = Net Income
Total Assets ✕ 100%
Total Assets ✕ 100%
RNAZ ROA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -55.0% | -5.1% |
| 3 y3 years | -61.5% | -320.6% |
| 5 y5 years | -20.8% | - |
RNAZ ROA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -1102.7% | at low | -728.7% | at low |
| 5 y | 5-year | -1102.7% | at low | -728.7% | +56.6% |
| alltime | all time | -1102.7% | at low | -728.7% | +56.6% |
TransCode Therapeutics ROA History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -281.35%(+8.1%) |
| Jun 2024 | - | -260.32%(+9.0%) |
| Mar 2024 | - | -238.80%(-13.5%) |
| Dec 2023 | -358.75%(+55.0%) | -276.09%(+3.2%) |
| Sep 2023 | - | -267.59%(+11.9%) |
| Jun 2023 | - | -239.19%(+24.4%) |
| Mar 2023 | - | -192.24%(+43.9%) |
| Dec 2022 | -231.48% | -133.55%(+49.0%) |
| Sep 2022 | - | -89.64%(+37.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | -65.29%(+92.3%) |
| Mar 2022 | - | -33.95%(-36.9%) |
| Dec 2021 | -29.83%(-86.6%) | -53.82%(-19.5%) |
| Sep 2021 | - | -66.89%(-79.3%) |
| Jun 2021 | - | -322.72%(-50.2%) |
| Mar 2021 | - | -648.41%(+192.0%) |
| Dec 2020 | -222.09%(-25.2%) | - |
| Dec 2020 | - | -222.09% |
| Dec 2019 | -296.92% | - |
FAQ
- What is TransCode Therapeutics annual return on assets?
- What is the all time high annual ROA for TransCode Therapeutics?
- What is TransCode Therapeutics annual ROA year-on-year change?
- What is TransCode Therapeutics quarterly return on assets?
- What is the all time high quarterly ROA for TransCode Therapeutics?
- What is TransCode Therapeutics quarterly ROA year-on-year change?
What is TransCode Therapeutics annual return on assets?
The current annual ROA of RNAZ is -358.75%
What is the all time high annual ROA for TransCode Therapeutics?
TransCode Therapeutics all-time high annual return on assets is -29.83%
What is TransCode Therapeutics annual ROA year-on-year change?
Over the past year, RNAZ annual return on assets has changed by -127.27% (-54.98%)
What is TransCode Therapeutics quarterly return on assets?
The current quarterly ROA of RNAZ is -281.35%
What is the all time high quarterly ROA for TransCode Therapeutics?
TransCode Therapeutics all-time high quarterly return on assets is -33.95%
What is TransCode Therapeutics quarterly ROA year-on-year change?
Over the past year, RNAZ quarterly return on assets has changed by -13.76% (-5.14%)